AI assistant
Sending…
RESMED INC — Director's Dealing 2020
Feb 12, 2020
30071_dirs_2020-02-12_46884aa4-cc74-46e4-bd35-c5982d4c57fa.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2020-02-10
Reporting Person: McHale Richard (President, RC Business)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-02-10 | ResMed Common Stock | S | 3000 | $172.6345 | Disposed | 17670 | Direct |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $172.59 to 172.65. The price reported above reflects the weighted average sale price.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Regulatory Filings
2026
Jan 29